METACEL PHARMS LLC
PharmaMETACEL PHARMS LLC is a pharmaceutical company focused on Neurology. Key products include OZOBAX DS.
METACEL PHARMS LLC's Key Drugs
METACEL PHARMS LLC's core commercial portfolio centers on OZOBAX DS, spanning Neurology — its most strategically important drugs approved in the last 15 years.
METACEL PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for METACEL PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
METACEL PHARMS LLC's Therapeutic Areas
METACEL PHARMS LLC's approved drugs and pipeline span 1 therapeutic area, led by Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
METACEL PHARMS LLC's Top Competitors
METACEL PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
METACEL PHARMS LLC Pipeline Snapshot
Active clinical trials for METACEL PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • OZOBAX DS leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling